Newest X500 Mass Spec System is the
first true benchtop, accurate mass system for simple,
robust and rapid biologics characterization during drug development
Singapore – February 01, 2016 – SCIEX, a
global leader in life science analytical technologies, today announced their
latest solution in the X-Series Quadrupole Time of Flight (QTOF) mass
spectrometry (MS) platform. The newest X-Series model, the X500B QTOF System,
brings simplicity, high-performance, and robustness for
biotherapeutic analyses to one of the most compact mass spectrometry system MS system
footprints on the market. The new user-friendly SCIEX OS Software interface and powerful BioPharmaViewTM 2.0 processing software comprise
an unmatched integrated LC-MS solution for mass spec experts, or novices,
performing standard biotherapeutic characterization.
The X500R QTOF System
emerged in 2015 as the first LC-MS solution designed specifically for routine
food, environmental and forensic testing, and introduced an entirely new
industrial design, fully-loaded with easy to use software, methods and
libraries, custom-designed for targeted customer applications. The X500R QTOF
has since won awards and achieved accolades by industry leading laboratories
and key opinion leaders.
Like the X500R, the X500B QTOF
System was specifically developed to deliver ease-of-use for high resolution standardized
workflows, for biotherapeutic developers, who are required to fully
characterize biologic products in large numbers during the development process.
Many MS-based workflows require users to be mass spectrometry system experts
and they must perform complicated data processing and manual calculations. The
workflows can be complex to setup and involve intensive and sometimes confusing
software. The X500B QTOF offers the robust and streamlined, quality instrumentation
SCIEX is known for, with the intuitive SCIEX OS user interface for simplified
workflow setup.
To simplify complex data processing
the X500B QTOF System comes with BioPharmaView Software 2.0, enabling
scientists to generate better information, faster. BioPharmaView Mass Spec
Software also offers the ability
to interpret SWATH® 2.0 data independent acquisition on the X500B QTOF
System. SWATH acquisition allows for comprehensive peptide mapping data to be
acquired in a single injection, with high-resolution MS and MSMS data for every
peptide in the sample. This strategy results in the ability to detect important
low abundance peptides and post-translational modifications that may be missed
with other approaches. With the X500B
QTOF System, all users can achieve expert level results in their biotherapeutic
characterization workflows.
“Mass
spec users have been asking for systems that are purpose built for their
application, and SCIEX has listened,” said Farzana Azam, Senior Director,
Pharmaceutical/CRO Business at SCIEX. “The introduction of X500B system
brings a new level of simplicity, robustness and integration to simplify the
complex world of biologics characterization. The combination of this innovative
true benchtop QTOF system and software like SCIEX OS, and unique SWATH
Acquisition, creates the complete easy-to-use and streamlined solution for
standard biologic analyses.”
SCIEX will be
presenting the X500B at the CASSS WCBP 21st Symposium, January 24 –
26, 2017.
Learn more about the
X500B from SCIEX at sciex.com/X500B
and sciex.com/OS
About SCIEX
SCIEX
helps to improve the world we live in by enabling scientists and laboratory
analysts to find answers to the complex analytical challenges they face. The
company’s global leadership and world-class service and support in the
capillary electrophoresis and liquid chromatography-mass spectrometry industry
have made it a trusted partner to thousands of the scientists and lab analysts
worldwide who are focused on basic research, drug discovery and development,
food and environmental testing, forensics and clinical research.
With
over 40 years of proven innovation, SCIEX excels by listening to and
understanding the ever-evolving needs of its customers to develop reliable,
sensitive and intuitive solutions that continue to redefine what is achievable
in routine and complex analysis. For more information, please visit sciex.com.
SCIEX
social: Twitter: @SCIEXnews, LinkedIn and Facebook.
For
Research Use Only. Not for use in diagnostic procedures.
AB
Sciex is operating as SCIEX.
©
2016 AB Sciex. The trademarks mentioned herein are the property of the AB Sciex
Pte. Ltd. or their respective owners. AB Sciex™ is being used under license. RUO-MKT-12-4534-A
###
